164 related articles for article (PubMed ID: 12784873)
1. Classification of glioblastoma multiforme in adults by molecular genetics.
Benjamin R; Capparella J; Brown A
Cancer J; 2003; 9(2):82-90. PubMed ID: 12784873
[TBL] [Abstract][Full Text] [Related]
2. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
3. [Biology molecular of glioblastomas].
Franco-Hernández C; Martínez-Glez V; Rey JA
Neurocirugia (Astur); 2007 Oct; 18(5):373-82. PubMed ID: 18008011
[TBL] [Abstract][Full Text] [Related]
4. Primary and secondary glioblastomas: from concept to clinical diagnosis.
Kleihues P; Ohgaki H
Neuro Oncol; 1999 Jan; 1(1):44-51. PubMed ID: 11550301
[TBL] [Abstract][Full Text] [Related]
5. Comparative genetic patterns of glioblastoma multiforme: potential diagnostic tool for tumor classification.
Wiltshire RN; Rasheed BK; Friedman HS; Friedman AH; Bigner SH
Neuro Oncol; 2000 Jul; 2(3):164-73. PubMed ID: 11302337
[TBL] [Abstract][Full Text] [Related]
6. Early genetic changes involved in low-grade astrocytic tumor development.
Arjona D; Rey JA; Taylor SM
Curr Mol Med; 2006 Sep; 6(6):645-50. PubMed ID: 17022734
[TBL] [Abstract][Full Text] [Related]
7. Studying a complex tumor: potential and pitfalls.
Zheng S; Chheda MG; Verhaak RG
Cancer J; 2012; 18(1):107-14. PubMed ID: 22290264
[TBL] [Abstract][Full Text] [Related]
8. Oncogenes: cause or consequence in the development of glial tumors.
Akbasak A; Sunar-Akbasak B
J Neurol Sci; 1992 Sep; 111(2):119-33. PubMed ID: 1331337
[TBL] [Abstract][Full Text] [Related]
9. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.
von Deimling A; Louis DN; von Ammon K; Petersen I; Hoell T; Chung RY; Martuza RL; Schoenfeld DA; Yaşargil MG; Wiestler OD
J Neurosurg; 1992 Aug; 77(2):295-301. PubMed ID: 1320666
[TBL] [Abstract][Full Text] [Related]
10. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
[TBL] [Abstract][Full Text] [Related]
11. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course.
Jesionek-Kupnicka D; Kulczycka D; Rieske P; Szybka M; Jabłońska J; Potemski P; Kolasa P; Liberski PP; Kordek R
Pol J Pathol; 2007; 58(2):79-85. PubMed ID: 17715673
[TBL] [Abstract][Full Text] [Related]
12. Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization.
Weber RG; Sommer C; Albert FK; Kiessling M; Cremer T
Lab Invest; 1996 Jan; 74(1):108-19. PubMed ID: 8569172
[TBL] [Abstract][Full Text] [Related]
13. Emerging insights into the molecular and cellular basis of glioblastoma.
Dunn GP; Rinne ML; Wykosky J; Genovese G; Quayle SN; Dunn IF; Agarwalla PK; Chheda MG; Campos B; Wang A; Brennan C; Ligon KL; Furnari F; Cavenee WK; Depinho RA; Chin L; Hahn WC
Genes Dev; 2012 Apr; 26(8):756-84. PubMed ID: 22508724
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
[TBL] [Abstract][Full Text] [Related]
15. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G
Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190
[TBL] [Abstract][Full Text] [Related]
16. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.
Smith JS; Tachibana I; Passe SM; Huntley BK; Borell TJ; Iturria N; O'Fallon JR; Schaefer PL; Scheithauer BW; James CD; Buckner JC; Jenkins RB
J Natl Cancer Inst; 2001 Aug; 93(16):1246-56. PubMed ID: 11504770
[TBL] [Abstract][Full Text] [Related]
17. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
18. Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.
Parvez T
Technol Cancer Res Treat; 2008 Jun; 7(3):241-8. PubMed ID: 18473496
[TBL] [Abstract][Full Text] [Related]
19. Genetic studies and molecular markers of bladder cancer.
Cordon-Cardo C; Sheinfeld J; Dalbagni G
Semin Surg Oncol; 1997; 13(5):319-27. PubMed ID: 9259087
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of radiographically defined de novo glioblastoma multiforme.
Tortosa A; Ino Y; Odell N; Swilley S; Sasaki H; Louis DN; Henson JW
Neuropathol Appl Neurobiol; 2000 Dec; 26(6):544-52. PubMed ID: 11123721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]